A mutation needs a very significant advantage that would let it successfully rampage through a large population with significant levels of immunity. The manufacturers are working on the modified vaccines already and would adapt again, if a new variant emerged. Whilst annual boosters are to be expected, they may be more frequent for the shorter term.
Mutations happen but need hiigh volumes of people infected to occur in large numbers. Many will become dead ends, if they have minimal advantages and all fail unless they are passed on to others. With increasing density of people with immunity, it becomes ever more difficult for them to be passed on to other people. With reducing numbers of people infected, the volume of mutations falls. If mutations occur in other populations that evade the immunity gained from the vaccines, they could gain a footing if introduced. As our infection numbers fall, it allows resources to be more tightly focused on the specifics of the smaller number of people who are infected. We should not be stopping our virus monitoring for a long time. |
Reply privately, Reply in forum +quote
or View forums list | |
"Just as France reports it has not been outdone by the UK. The Brittany strain is a lot harder to detect. Think we should let them keep that one. "
You'll find it near the fromage counter at sainsburys |
Reply privately, Reply in forum +quote
or View forums list | |
 |
By (user no longer on site)
over a year ago
|
It won’t matter how many are vaccinated, this will not go away, you will have to be on your guard for many years to come and this will become the norm.
anyone who thinks they are going abroad for their holidays this year your going to be very disappointed but then again anyone who even thinks about going on an aero plane must need their head testing
|
Reply privately, Reply in forum +quote
or View forums list | |
» Add a new message to this topic
